annual EBITDA:
-$14.10M-$2.23M(-18.75%)Summary
- As of today (September 18, 2025), PVLA annual EBITDA is -$14.10 million, with the most recent change of -$2.23 million (-18.75%) on December 31, 2024.
- During the last 3 years, PVLA annual EBITDA has risen by +$35.37 million (+71.50%).
- PVLA annual EBITDA is now -1601.86% below its all-time high of $938.50 thousand, reached on December 1, 2013.
Performance
PVLA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$9.25M-$1.38M(-17.52%)Summary
- As of today (September 18, 2025), PVLA quarterly EBITDA is -$9.25 million, with the most recent change of -$1.38 million (-17.52%) on June 30, 2025.
- Over the past year, PVLA quarterly EBITDA has dropped by -$6.34 million (-218.09%).
- PVLA quarterly EBITDA is now -240.40% below its all-time high of $6.59 million, reached on December 1, 2017.
Performance
PVLA quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$20.26M-$6.34M(-45.58%)Summary
- As of today (September 18, 2025), PVLA TTM EBITDA is -$20.26 million, with the most recent change of -$6.34 million (-45.58%) on June 30, 2025.
- Over the past year, PVLA TTM EBITDA has dropped by -$13.71 million (-209.39%).
- PVLA TTM EBITDA is now -1919.46% below its all-time high of $1.11 million, reached on December 1, 2013.
Performance
PVLA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PVLA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.8% | -218.1% | -209.4% |
| 3 y3 years | +71.5% | +21.3% | +57.1% |
| 5 y5 years | +46.0% | -124.2% | +1.7% |
PVLA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.8% | +71.5% | -341.8% | +38.1% | -2280.3% | +58.7% |
| 5 y | 5-year | -18.8% | +71.5% | -341.8% | +49.8% | -2280.3% | +60.8% |
| alltime | all time | -1601.9% | +71.5% | -240.4% | +49.8% | -1919.5% | +60.8% |
PVLA EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$9.25M(+17.5%) | -$20.26M(+45.6%) |
| Mar 2025 | - | -$7.87M(+151.1%) | -$13.91M(+3.0%) |
| Dec 2024 | -$14.10M(+18.8%) | - | - |
| Sep 2024 | - | -$3.13M(+7.8%) | -$13.51M(+106.3%) |
| Jun 2024 | - | -$2.91M(+65.3%) | -$6.55M(+669.3%) |
| Mar 2024 | - | -$1.76M(-69.2%) | -$851.00K(-93.9%) |
| Dec 2023 | -$11.87M(-70.8%) | -$5.71M(-249.2%) | -$14.03M(-27.1%) |
| Sep 2023 | - | $3.83M(+37.2%) | -$19.26M(-44.1%) |
| Jun 2023 | - | $2.79M(-118.7%) | -$34.48M(-29.7%) |
| Mar 2023 | - | -$14.94M(+36.6%) | -$49.03M(+20.4%) |
| Dec 2022 | -$40.69M(-17.7%) | -$10.93M(-4.1%) | -$40.70M(+1.3%) |
| Sep 2022 | - | -$11.40M(-3.1%) | -$40.18M(-14.9%) |
| Jun 2022 | - | -$11.76M(+77.7%) | -$47.21M(-8.5%) |
| Mar 2022 | - | -$6.62M(-36.4%) | -$51.62M(+4.4%) |
| Dec 2021 | -$49.46M(+55.6%) | -$10.41M(-43.5%) | -$49.46M(-2.7%) |
| Sep 2021 | - | -$18.43M(+14.0%) | -$50.86M(+13.2%) |
| Jun 2021 | - | -$16.17M(+262.6%) | -$44.93M(+36.6%) |
| Mar 2021 | - | -$4.46M(-62.2%) | -$32.89M(+3.6%) |
| Dec 2020 | -$31.79M(+21.7%) | -$11.80M(-5.6%) | -$31.75M(+54.1%) |
| Sep 2020 | - | -$12.50M(+203.1%) | -$20.60M(+89.8%) |
| Jun 2020 | - | -$4.13M(+24.3%) | -$10.86M(-42.6%) |
| Mar 2020 | - | -$3.32M(+405.0%) | -$18.92M(-27.6%) |
| Dec 2019 | -$26.12M | -$657.00K(-76.2%) | -$26.12M(-31.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$2.75M(-77.4%) | -$37.94M(-11.5%) |
| Jun 2019 | - | -$12.19M(+15.9%) | -$42.86M(+30.8%) |
| Mar 2019 | - | -$10.52M(-15.7%) | -$32.78M(+8.3%) |
| Dec 2018 | -$30.26M(+112.7%) | -$12.48M(+62.7%) | -$30.26M(+170.4%) |
| Sep 2018 | - | -$7.67M(+265.1%) | -$11.19M(+29.4%) |
| Jun 2018 | - | -$2.10M(-73.7%) | -$8.65M(-39.6%) |
| Mar 2018 | - | -$8.00M(-221.5%) | -$14.32M(+0.7%) |
| Dec 2017 | -$14.22M(-36.5%) | $6.59M(-228.4%) | -$14.22M(-47.4%) |
| Sep 2017 | - | -$5.13M(-34.1%) | -$27.03M(-3.4%) |
| Jun 2017 | - | -$7.78M(-1.6%) | -$27.99M(+7.6%) |
| Mar 2017 | - | -$7.91M(+27.1%) | -$26.02M(+16.2%) |
| Dec 2016 | -$22.40M(+75.3%) | -$6.22M(+2.2%) | -$22.40M(+20.0%) |
| Sep 2016 | - | -$6.09M(+4.8%) | -$18.67M(+13.9%) |
| Jun 2016 | - | -$5.81M(+35.5%) | -$16.39M(+16.7%) |
| Mar 2016 | - | -$4.29M(+72.0%) | -$14.04M(+5.0%) |
| Dec 2015 | -$12.77M(+87.0%) | -$2.49M(-34.4%) | -$13.37M(+5.2%) |
| Sep 2015 | - | -$3.80M(+9.9%) | -$12.71M(+19.2%) |
| Jun 2015 | - | -$3.46M(-4.6%) | -$10.66M(+7.9%) |
| Mar 2015 | - | -$3.62M(+98.2%) | -$9.88M(+44.6%) |
| Dec 2014 | -$6.83M(-827.9%) | -$1.83M(+4.4%) | -$6.83M(+75.6%) |
| Sep 2014 | - | -$1.75M(-34.5%) | -$3.89M(+81.9%) |
| Jun 2014 | - | -$2.68M(+364.8%) | -$2.14M(-497.8%) |
| Mar 2014 | - | -$575.70K(-151.7%) | $537.60K(-51.7%) |
| Dec 2013 | $938.50K | $1.11M | $1.11M |
FAQ
- What is Palvella Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Palvella Therapeutics, Inc.?
- What is Palvella Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Palvella Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Palvella Therapeutics, Inc.?
- What is Palvella Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Palvella Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Palvella Therapeutics, Inc.?
- What is Palvella Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Palvella Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of PVLA is -$14.10M
What is the all time high annual EBITDA for Palvella Therapeutics, Inc.?
Palvella Therapeutics, Inc. all-time high annual EBITDA is $938.50K
What is Palvella Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, PVLA annual EBITDA has changed by -$2.23M (-18.75%)
What is Palvella Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of PVLA is -$9.25M
What is the all time high quarterly EBITDA for Palvella Therapeutics, Inc.?
Palvella Therapeutics, Inc. all-time high quarterly EBITDA is $6.59M
What is Palvella Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, PVLA quarterly EBITDA has changed by -$6.34M (-218.09%)
What is Palvella Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of PVLA is -$20.26M
What is the all time high TTM EBITDA for Palvella Therapeutics, Inc.?
Palvella Therapeutics, Inc. all-time high TTM EBITDA is $1.11M
What is Palvella Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, PVLA TTM EBITDA has changed by -$13.71M (-209.39%)